sPLS-DA models incorporating all 26 CSF markers used to stratify either HD mutation carriers and controls (AUC = 0.90) or preHD and controls (AUC = 0.88) showed discriminatory performances similar to PENK alone. This evidence concerns the gene PENK and Huntington disease.